RedHill Biopharma (RDHL) Return on Sales Growth (3y) (2015 - 2023)
RedHill Biopharma (RDHL) Return on Sales Growth (3y) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.00 |
| 10 | RedHill Biopharma | 640,064.98 | 640,064.98 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 32.00 |
| Mar 31, 2023 | -18.00 |
| Dec 31, 2022 | -13.00 |
| Sep 30, 2022 | -9.00 |
| Jun 30, 2022 | -9.00 |
| Mar 31, 2022 | -4.00 |
| Dec 31, 2021 | -15.00 |
| Sep 30, 2021 | -4.00 |
| Jun 30, 2021 | -2.00 |
| Mar 31, 2021 | -3.00 |
| Dec 31, 2020 | -8.00 |
| Sep 30, 2020 | -8.00 |
| Jun 30, 2020 | -33.00 |
| Mar 31, 2020 | 2,337.00 |
| Jun 30, 2019 | -7,827.00 |
| Dec 31, 2018 | -90.00 |
| Jun 30, 2018 | -5,181.00 |
| Mar 31, 2018 | -4,864.00 |
| Dec 31, 2017 | -3,973.00 |
| Sep 30, 2017 | 8.00 |